Evidence map›Paper›PMID 23673893›Full record

Trial reportJournal of acquired immune deficiency syndromes (1999)2013

Rate of decay in proportion of condom-protected sex acts among adolescents after participation in an HIV risk-reduction intervention.

Ralph J DiClemente, Jennifer L Brown, Jessica M Sales, Eve S Rose

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of acquired immune deficiency syndromes (1999), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ralph J DiClementeDepartment of Behavioral Sciences and Health Education, Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA. rdiclem@emory.edu
Jennifer L Brown
Jessica M Sales
Eve S Rose

Funding

Virology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Carlos del Rio · 2002 to 2026
$74.0M
IRACDA Fellowships in Research and Science Training (FIRST)K12GM000680 · NIGMS · EMORY UNIVERSITY · PI BROWN, LOU ANN S, MCCARTY, NAEL A · 2000 to 2024
$41.2M
Atlanta Clinical and Translational Science Institute (ACTSI) RenewalUL1TR000454 · NCATS · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2012 to 2016
$25.8M
Vulnerability to Drug Use & HIV: Advancing Prevention for Rural African AmericansP30DA027827 · NIDA · UNIVERSITY OF GEORGIA · PI BRODY, GENE H. · 2009 to 2018
$10.2M
HIV Prevention Maintenance for African American Teens ContinuationR01MH070537 · NIMH · EMORY UNIVERSITY · PI DICLEMENTE, RALPH J · 2003 to 2012
$6.8M
Factors Associated with Teens' Non-Responsiveness to HIV InterventionK01MH085506 · NIMH · EMORY UNIVERSITY · PI SALES, JESSICA A · 2009 to 2013
$686k
The CFAR Social & Behavioral Science Research Network National Scientific MeetingR13MH081733 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI BLANK, MICHAEL B · 2008 to 2010
$223k
NCATS NIH HHS UL1 TR000454NCATS NIH HHS UL1TR000454NIAID NIH HHS P30 AI050409NIDA NIH HHS P03 DA027827NIDA NIH HHS P30 DA027827NIGMS NIH HHS K12 GM000680NIMH NIH HHS 5R01MH070537NIMH NIH HHS K01 MH085506NIMH NIH HHS K01MH085506NIMH NIH HHS R01 MH070537NIMH NIH HHS R13 MH-081733-01A1
6 · The paper itself

Abstract

objectiveHIV risk-reduction interventions have demonstrated efficacy in enhancing the proportion of condom-protected sex (CPS) acts among diverse populations. Although postintervention exposure increase in CPS are often observed, there is scant empirical data quantifying decay of intervention efficacy (declines in CPS after cessation of the intervention among participants reporting an initial postintervention increase in CPS). Thus, the objective of this study was to quantify the rate of decay in intervention efficacy over a 24-month follow-up.

designAfrican American adolescent females (ages: 14-20; n = 349) completed a baseline audio computer-assisted self-administered interview, participated in an HIV risk-reduction intervention, and were assessed at 6-month intervals for 24 months postintervention. Intervention efficacy was conceptualized as an increase in participants' CPS relative to baseline.

methodsAnalyses focused on the subset of participants who reported an initial increase in CPS from baseline to the 6-month postintervention assessment (n = 121) to quantify the rate of decay in intervention efficacy over a 24-month follow-up period.

resultsCPS increased markedly from baseline to 6-month follow-up assessment. However, from 6 to 12 months, a marked decline in CPS was observed. Further CPS declines, though not statistically significant, were observed from 12 to 18 months and 18 to 24 months. Cumulative reductions in CPS over the entire 24-month follow-up resulted in no statistical difference between baseline and 24-month follow-up; indicative of a nonsignificant intervention effect at 24-month assessment.

conclusionsInnovative postintervention optimization strategies are needed to minimize CPS decay over protracted time periods by reinforcing, sustaining, and potentially amplifying initial gains in condom use.

Indexed as

Black or African AmericanAdolescentCondomsFemaleFollow-Up StudiesHealth PromotionHIVHIV InfectionsHumansProgram EvaluationRisk Reduction BehaviorSafe SexWomen's HealthYoung Adult

Identifiers

PMID23673893
PMCPMC3662369

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.